4P-Pharma at MEET2WIN 2018

We are thrilled to announce that 4P-Pharma was selected among 150 applicants to participate in The Hive, Elsevier’s pharma and biotech start-ups  initiative to accelerate innovation. 4P-Pharma, and the 5 other selected companies selected for The Hive, will receive complimentary  access to Elsevier’s suite of information solutions for 18 months. The Hive program and Elsevier’s&hellip

4P-Pharma is a recognized actor in the ADHD pipeline drug development. Stimulant abuse and addiction is surging and is becoming a major global health problem. Recently, the CDC released worrisome data on psychostimulants-related overdose death, with a 33,3% increase from 2015-2016*. Last April, at the National Rx Drug Abuse and Heroin Summit, experts warned of&hellip